MARKET

CTLT

CTLT

Catalent
NYSE

Real-time Quotes | Nasdaq Last Sale

51.71
+2.78
+5.68%
Opening 11:28 04/06 EDT
OPEN
51.24
PREV CLOSE
48.93
HIGH
52.25
LOW
50.55
VOLUME
338.17K
TURNOVER
--
52 WEEK HIGH
68.78
52 WEEK LOW
31.04
MARKET CAP
8.01B
P/E (TTM)
58.65
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CTLT stock price target is 66.50 with a high estimate of 75.00 and a low estimate of 57.00.

EPS

CTLT News

More
  • Do Hedge Funds Love Catalent Inc (CTLT)?
  • Insider Monkey · 03/23 05:12
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • What Does Catalent, Inc.'s (NYSE:CTLT) P/E Ratio Tell You?
  • Simply Wall St. · 03/17 12:07
  • A Sliding Share Price Has Us Looking At Catalent, Inc.'s (NYSE:CTLT) P/E Ratio
  • Simply Wall St. · 03/17 11:48

Industry

Pharmaceuticals
+2.92%
Pharmaceuticals & Medical Research
+3.11%

Hot Stocks

Symbol
Price
%Change

About CTLT

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.
More

Webull offers kinds of Catalent Inc stock information, including NYSE:CTLT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTLT stock news, and many more online research tools to help you make informed decisions.